Oxana Beskrovnaya Dyne Therapeutics, Inc. (DYN) insider trading activity

DYN Quotes by TradingView

Oxana Beskrovnaya is Chief Scientific Officer of Dyne Therapeutics, Inc.. Currently has a direct ownership of 201,685 shares of DYN, which is worth approximately $5.26 Million. The most recent transaction as insider was on Dec 11, 2024, when has been sold 2,334 shares (Common Stock) at a price of $28.12 per share, resulting in proceeds of $65,632. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 202K
41.32% 3M change
14.21% 12M change
Total Value Held $5.26 Million

Oxana Beskrovnaya Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 11 2024
SELL
Open market or private sale
$65,632 $28.12 p/Share
2,334 Reduced 1.14%
201,685 Common Stock
Dec 04 2024
BUY
Grant, award, or other acquisition
-
66,500 Added 24.58%
204,019 Common Stock
Nov 18 2024
SELL
Open market or private sale
$80,539 $28.2 p/Share
2,856 Reduced 2.03%
137,519 Common Stock
Sep 18 2024
SELL
Open market or private sale
$80,812 $34.55 p/Share
2,339 Reduced 1.64%
140,375 Common Stock
Sep 11 2024
SELL
Open market or private sale
$68,914 $31.89 p/Share
2,161 Reduced 1.49%
142,714 Common Stock
Aug 19 2024
SELL
Open market or private sale
$119,938 $45.5 p/Share
2,636 Reduced 1.79%
144,875 Common Stock
Jun 11 2024
SELL
Open market or private sale
$66,942 $31.34 p/Share
2,136 Reduced 1.43%
147,511 Common Stock
May 20 2024
SELL
Open market or private sale
$1,015,011 $33.36 p/Share
30,426 Reduced 16.9%
149,647 Common Stock
May 20 2024
BUY
Exercise of conversion of derivative security
$31,338 $1.03 p/Share
30,426 Added 14.45%
180,073 Common Stock
May 16 2024
SELL
Open market or private sale
$76,822 $28.4 p/Share
2,705 Reduced 1.78%
149,647 Common Stock
Mar 11 2024
SELL
Open market or private sale
$53,481 $25.7 p/Share
2,081 Reduced 1.35%
152,352 Common Stock
Mar 07 2024
SELL
Open market or private sale
$61,342 $25.85 p/Share
2,373 Reduced 1.51%
154,433 Common Stock
Jan 04 2024
SELL
Open market or private sale
$769,672 $18.13 p/Share
42,453 Reduced 21.31%
156,806 Common Stock
Jan 04 2024
BUY
Exercise of conversion of derivative security
$23,354 $1.03 p/Share
22,674 Added 10.22%
199,259 Common Stock
Jan 03 2024
SELL
Open market or private sale
$874,791 $19.3 p/Share
45,326 Reduced 20.43%
176,585 Common Stock
Jan 03 2024
BUY
Exercise of conversion of derivative security
$46,685 $1.03 p/Share
45,326 Added 16.96%
221,911 Common Stock
Dec 11 2023
SELL
Open market or private sale
$15,726 $10.72 p/Share
1,467 Reduced 0.82%
176,585 Common Stock
Nov 15 2023
BUY
Grant, award, or other acquisition
-
93,718 Added 34.48%
178,052 Common Stock
Sep 18 2023
SELL
Open market or private sale
$13,512 $9.41 p/Share
1,436 Reduced 1.67%
84,334 Common Stock
Sep 12 2023
SELL
Open market or private sale
$15,448 $10.41 p/Share
1,484 Reduced 1.7%
85,770 Common Stock
Jun 13 2023
SELL
Open market or private sale
$18,334 $12.43 p/Share
1,475 Reduced 1.66%
87,254 Common Stock
Mar 14 2023
SELL
Open market or private sale
$18,875 $13.33 p/Share
1,416 Reduced 1.57%
88,729 Common Stock
Dec 12 2022
SELL
Open market or private sale
$7,391 $10.87 p/Share
680 Reduced 0.75%
90,145 Common Stock
Dec 09 2022
BUY
Grant, award, or other acquisition
-
40,000 Added 30.58%
90,825 Common Stock
Sep 20 2022
SELL
Sale (or disposition) back to the issuer
$19,358 $13.7 p/Share
1,413 Reduced 2.7%
50,825 Common Stock
OB

Oxana Beskrovnaya

Chief Scientific Officer
Waltham, MA

Track Institutional and Insider Activities on DYN

Follow Dyne Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DYN shares.

Notify only if

Insider Trading

Get notified when an Dyne Therapeutics, Inc. insider buys or sells DYN shares.

Notify only if

News

Receive news related to Dyne Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DYN